EFFECTS OF LACTIC ACID BACTERIA PROBIOTIC ON URINARE OXALATE EXCRETION AND PREVENTION OF RECURRENT PYELONEPHRITIS
Journal Title: УКРАЇНСЬКИЙ ЖУРНАЛ НЕФРОЛОГІЇ ТА ДІАЛІЗУ - Year 2017, Vol 4, Issue 56
Abstract
The present study was performed to evaluate the ability of Lactobacillus probiotics to reduce the urinary oxalate excretion level and prevent recurrent pyelonephritis. Methods. The open, 6 months randomized controlled trial was followed up. 80 women with recurrent pyelonephritis, caused by E. coli or S. faecalis, were randomly allocated into 2 groups. The 1st Group (n = 40) took Symbiform® which contained acidophilic and plantar Lactobacilli, Lactococci (lactis and cremoris), Bifidobacteria (adolescentis and bifidum) and thermophilic non–pathogenic Streptococcus. The 2nd one (n = 40) received oxalate–soluble herbal remedy Uronefron® containing 188 mg of city extract from 9 plants. Probiotic was prescribed in a dose of 1 sachet 2 times a day during the first 5 days, followed by a dose reduction of 1 sachet per day for a month. Uronefron® was prescribed in a dose of 3 pills a day for a month. Results. 1 month after the end of the treatment, microbiological studies of the colon microflora demonstrated the increasing level of Lactobacillus spp. colonization more than 7 million CPU/1 g of faeces: 35/40 (87.5 %) in the patients of the 1st Group vs 6/40 (15 %) in the women of the comparison Group f/f = 41.5; p < 0.0001). The levels of daily urinary oxalate excretion were significantly decreased in both groups: the patients of Probiotic Group: 117.6 ± 11.7 vs 71.9 ± 10.07mg/d after the treatment (p < 0.0001) and 122.02 ± 17 vs 84.8 ± 9.8 mg/d (p < 0.0001) in the women of the 2nd Group, respectively. In the 6 months preceding randomization, at least 1 recurrence of pyelonephritis occurred in 2/40 (5 %) women of the Probiotic Group and 9/40 (22.5 %) in the patients of Group II (//= 5,1; p = 0,02). Conclusions. The use of lactobacillus probiotics in non–stone fanners women with recurrent pyelonephritis increases the quantitative content of Lactobacillus spp. in the gut, reduces daily urinary oxalate excretion and the number of pyelonephritis recurrences.
Authors and Affiliations
N. M. Stepanova, N. Stashevska, L. Lebid, M. Kolesnyk
Half a century of IgA nephropathy: achievements, frustrations and challenges
IgA nephropathy is the most common glomerulonephritis worldwide. This disease has a tremendous economic impact because renal replacement therapy is expensive and hard-to-reach. It also represents a social problem because...
ДОПЛЕРОГРАФІЧНА ХАРАКТЕРИСТИКА ПОРУШЕНЬ НИРКОВОГО КРОВООБІГУ У ХВОРИХ НА ХРОНІЧНУ ХВОРОБУ НИРОК І-ІІ СТАДІЇ З АРТЕРІАЛЬНОЮ ГІПЕРТЕНЗІЄЮ
Метою роботи було дослідити порушення ниркового кровообігу у хворих на хронічну хворобу нирок І-ІІ стадії (пієлонефрит, гломерулонефрит, діабетична нефропатія). Матеріали і методи: Було проведено 131 комплексне ультразв...
Можливість використання цитруліну як нового біохімічного маркеру оцінки стану нирок у пацієнтів з серцево-судинною патологією
Метою нашої роботи було дослідження рівня цитруліну в сироватці крові як біохімічного маркера функціонального стану нирок у пацієнтів з серцево-судинними патологіями. Методи. В дослідження було включено 134 пацієнта у в...
RELATIONSHIP OF THE CONDITION OF THE MYOCARDIUM WITH INFRINGEMENTS THE CALCIUM AND PHOSPHORUS METABOLISM INPATIENTS WITH DIABETIC NEPHROPATHY
Objective: To establish the possible relationship between changes in cardiac hemodynamics and im-paired phosphate-calcium metabolism and content FGF 23.Patients and Methods: 260 people with diabetic nephropat...
The level of prolactin in patient with CKD V stage, which are treated with hemodialysis
The prevalence of hyperprolactinemia in patients treated with hemodialysis (HD) is 30-65%. Aim of our work was to investigate the prolactin (PL) level in patients treated with hemodialysis. Methods. An open prospective...